…
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It offers Pivot product, a tubeless insulin delivery system that integrates the set into a true tubeless patch. Modular Medical, Inc. is headquartered in San Diego, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Publicly available information on Modular Medical Inc (NASDAQ: MODD) is limited, with filings providing few specifics about product lines, market focus, or operating history. The company's long-term outlook therefore depends on successful development and commercialization of its offerings and potential strategic partnerships, which may attract investors seeking early-stage exposure in healthcare.
Material risks include uncertain product and clinical development outcomes, regulatory approval timing, likely need for additional capital with potential dilution, limited stock liquidity, and strong competition from established medical device and healthcare firms.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Income before tax | -28.24M | -18.82M | -17.47M | -13.88M | -18.63M |
| Net income | -28.24M | -18.82M | -17.47M | -13.88M | -18.63M |
| Selling general administrative | 7.59M | 4.35M | 4.65M | 4.82M | 7.20M |
| Selling and marketing expenses | - | - | 0.45M | - | - |
| Gross profit | -1.67M | -1.43M | -0.77M | - | - |
| Reconciled depreciation | 1.67M | 1.06M | 0.43M | 0.15M | 0.20M |
| Ebit | -27.56M | -18.82M | -17.47M | -13.88M | -14.93M |
| Ebitda | -25.89M | -17.76M | -17.04M | -13.72M | -14.36M |
| Depreciation and amortization | 1.67M | 1.06M | 0.43M | 0.15M | 0.57M |
| Operating income | -27.56M | -19.05M | -17.53M | -13.88M | -14.93M |
| Other operating expenses | 27.56M | 19.05M | 17.53M | 13.88M | 14.93M |
| Interest expense | - | - | - | -0.97M | 2.75M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net interest income | - | - | - | 0.00M | -2.75M |
| Income tax expense | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total revenue | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total operating expenses | 25.89M | 19.05M | 17.53M | 13.88M | 14.93M |
| Cost of revenue | 1.67M | 1.43M | 0.77M | - | - |
| Total other income expense net | -0.68M | 0.23M | 0.06M | 0.00M | -3.70M |
| Net income from continuing ops | -28.24M | -18.82M | -17.47M | -13.88M | -18.63M |
| Net income applicable to common shares | - | - | - | -13.88M | -18.63M |
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Total assets | 14.83M | 18.73M | 13.81M | 7.25M | 9.85M |
| Other current assets | 0.58M | 0.35M | 0.32M | 0.15M | 0.00M |
| Total liab | 1.87M | 1.66M | 2.27M | 2.17M | 1.01M |
| Total stockholder equity | 12.96M | 17.08M | 11.54M | 5.08M | 8.84M |
| Other current liab | 0.49M | 0.50M | 0.28M | 338.70M | 0.52M |
| Common stock | 0.01M | 0.05M | 0.03M | 0.01M | 0.01M |
| Capital stock | 0.01M | 0.05M | 0.03M | 0.01M | 0.01M |
| Retained earnings | -113.00M | -84.75M | -65.93M | -48.46M | -34.58M |
| Other assets | - | - | - | - | 0.10M |
| Cash | 6.94M | 13.10M | 9.23M | 3.80M | 9.08M |
| Total current liabilities | 1.87M | 1.26M | 1.46M | 0.98M | 0.97M |
| Current deferred revenue | - | - | - | -338.36M | - |
| Net debt | -6.55M | -12.28M | -8.04M | -2.25M | -8.89M |
| Short term debt | 0.39M | 0.42M | 0.37M | 0.36M | 0.14M |
| Short long term debt total | 0.39M | 0.82M | 1.19M | 1.55M | 0.18M |
| Other stockholder equity | 125.95M | 101.78M | 77.43M | 53.52M | 43.41M |
| Property plant equipment | - | - | - | 3.20M | 0.36M |
| Total current assets | 7.54M | 13.52M | 9.70M | 4.05M | 9.39M |
| Net tangible assets | - | - | - | 5.08M | 8.84M |
| Net receivables | 0.02M | 0.07M | 0.15M | - | - |
| Accounts payable | 0.99M | 0.34M | 0.80M | 0.29M | 0.30M |
| Non currrent assets other | 0.06M | - | - | - | 0.10M |
| Non current assets total | 7.29M | 5.22M | 4.11M | 3.20M | 0.46M |
| Capital lease obligations | 0.39M | 0.82M | 1.19M | 1.55M | 0.18M |
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Investments | - | -2.49M | -1.70M | -1.64M | -0.05M |
| Change to liabilities | - | - | - | -0.20M | 0.35M |
| Total cashflows from investing activities | -3.93M | -2.49M | -1.70M | -1.64M | -0.05M |
| Net borrowings | 0.00M | 0.00M | - | - | 4.14M |
| Total cash from financing activities | 21.53M | 22.08M | 21.09M | 7.37M | 17.92M |
| Change to operating activities | - | - | - | -0.01M | 0.73M |
| Net income | -28.24M | -18.82M | -17.47M | -13.88M | -18.63M |
| Change in cash | -6.15M | 3.86M | 5.43M | -5.28M | 7.61M |
| Begin period cash flow | 13.10M | 9.23M | 3.80M | 9.08M | 1.47M |
| End period cash flow | 6.94M | 13.10M | 9.23M | 3.80M | 9.08M |
| Total cash from operating activities | -23.75M | -15.72M | -13.95M | -11.01M | -10.26M |
| Issuance of capital stock | 17.55M | 20.82M | 20.34M | 7.37M | 13.79M |
| Depreciation | 1.67M | 1.06M | 0.77M | 0.15M | 0.20M |
| Other cashflows from financing activities | 21.53M | 1.25M | 0.74M | -1.64M | 6.24M |
| Change to netincome | - | - | - | 2.73M | 5.26M |
| Capital expenditures | 3.93M | 2.49M | 1.70M | 1.64M | 0.05M |
| Change in working capital | 0.19M | -0.39M | -0.09M | -0.21M | 0.42M |
| Stock based compensation | 1.78M | 2.38M | 2.70M | 2.72M | 4.03M |
| Other non cash items | 0.84M | 0.05M | 0.14M | 0.20M | 3.72M |
| Free cash flow | -27.68M | -18.21M | -15.65M | -12.65M | -10.31M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|
| MODD Modular Medical Inc |
0.37 27.82% |
1.70 | - | - | - | 1.95 | -3.21 |
| ABT Abbott Laboratories |
-0.36 0.33% |
109.56 | 25.97 | 17.24 | 3.57 | 3.20 | 16.75 |
| MDT Medtronic PLC |
-0.14 0.14% |
101.66 | 26.60 | 15.87 | 3.35 | 2.08 | 14.12 |
| SYK Stryker Corporation |
-0.84 0.26% |
325.03 | 29.23 | 16.86 | 4.18 | 4.51 | 17.16 |
| SEMHF Siemens Healthineers AG |
-2.15 4.12% |
49.85 | 39.57 | 21.32 | 3.01 | 3.29 | 16.92 |
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It offers Pivot product, a tubeless insulin delivery system that integrates the set into a true tubeless patch. Modular Medical, Inc. is headquartered in San Diego, California.
10740 Thornmint Road, San Diego, CA, United States, 92127
858 800 3500
51
| Name | Title | Year Born |
|---|---|---|
| Mr. Paul M. DiPerna | Founder, Pres, CFO, Sec., Treasurer & Chairman | 1959 |
| Mr. James E. Besser | Chief Exec. Officer | 1976 |
| Mr. Kevin Schmid | Chief Operating Officer | 1959 |
| Marc Goldman | Head of Engineering | NA |
| Mr. Paul M. DiPerna | Founder, Chairman, President, CFO & Treasurer | 1959 |
| Mr. James E. Besser | Chief Executive Officer | 1976 |
| Mr. James E. Besser | Chief Executive Officer | 1977 |
| Mr. David Bosshard | Head of International Operations | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.